CATALANO, FABIO
CATALANO, FABIO
100007 - Dipartimento di Medicina interna e specialità mediche
1476P Immunohistochemical (mIHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: Main results from the Meet-URO 18 study
2022-01-01 Rebuzzi, S. E.; Rescigno, P.; Signori, A.; Brunelli, M.; Galuppini, F.; Vellone, V. G.; Gaggero, G.; Maruzzo, M.; Milella, M.; Vignani, F.; Cavo, A.; Basso, U.; Catalano, F.; Murianni, V.; Cremante, M.; Damassi, A.; Llaja Obispo, M. A.; Banna, G. L.; Buti, S.; Fornarini, G.
802TiP Immune tumor microenvironment (TME) in correlation with peripheral blood immune biomarkers as prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: The multicentric retrospective Meet-URO 18 study
2020-01-01 Brunelli, M; Buti, S.; Rebuzzi, S. E.; Milella, M.; Vellone, V.; Bersanelli, M.; Maruzzo, M.; Basso, U.; Signori, A.; Martelli, V.; Catalano, F.; Damassi, A.; Murianni, V.; Merler, S.; Casartelli, C.; Fornarini, G.
Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients
2022-01-01 Dalmasso, B.; Puccini, A.; Catalano, F.; Borea, R.; Iaia, M. L.; Bruno, W.; Fornarini, G.; Sciallero, S.; Rebuzzi, S. E.; Ghiorzo, P.
Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study
2023-01-01 Rebuzzi, Sara Elena; Brunelli, Matteo; Galuppini, Francesca; Vellone, Valerio Gaetano; Signori, Alessio; Catalano, Fabio; Damassi, Alessandra; Gaggero, Gabriele; Rescigno, Pasquale; Maruzzo, Marco; Merler, Sara; Vignani, Francesca; Cavo, Alessia; Basso, Umberto; Milella, Michele; Panepinto, Olimpia; Mencoboni, Manlio; Sbaraglia, Marta; Dei Tos, Angelo Paolo; Murianni, Veronica; Cremante, Malvina; Llaja Obispo, Miguel Angel; Maffezzoli, Michele; Banna, Giuseppe Luigi; Buti, Sebastiano; Fornarini, Giuseppe
Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients
2022-01-01 Puccini, Alberto; Ponzano, Marta; Dalmasso, Bruna; Vanni, Irene; Gandini, Annalice; Puglisi, Silvia; Borea, Roberto; Cremante, Malvina; Bruno, William; Andreotti, Virginia; Allavena, Eleonora; Martelli, Valentino; Catalano, Fabio; Grassi, Massimiliano; Iaia, Maria Laura; Pirrone, Chiara; Pastorino, Alessandro; Fornarini, Giuseppe; Sciallero, Stefania; Ghiorzo, Paola; Pastorino, Lorenza
Feasibility of multiple immunoexpression assay for immune tumor micrornvironment (I-TME) on matched metastatic and primary renal cell carcinoma (RCC) for patient prognostication and predictiveness to immunotherapy (preliminary analyses of the Meet URO 18 study).
2021-01-01 Brunelli, Matteo; Rebuzzi, SARA ELENA; Vellone, VALERIO GAETANO; Sbaraglia, Marta; Gaggero, Gabriele; Fassan, Matteo; Maruzzo, Marco; Basso, Umberto; Bersanelli, Melissa; Damassi, Alessandra; Martelli, Valentino; Catalano, Fabio; Pierantoni, Francesco; Casartelli, Chiara; Merler, Sara; Businello, Gianluca; Milella, Michele; Buti, Sebastiano; Fornarini, Giuseppe
The prognostic role of baseline metabolic tumor burden and systemic inflammation biomarkers in metastatic castration-resistant prostate cancer patients treated with Radium-223: A proof of concept study
2020-01-01 Bauckneht, M.; Rebuzzi, S. E.; Signori, A.; Donegani, M. I.; Murianni, V.; Miceli, A.; Borea, R.; Raffa, S.; Damassi, A.; Ponzano, M.; Catalano, F.; Martelli, V.; Marini, C.; Boccardo, F.; Morbelli, S.; Sambuceti, G.; Fornarini, G.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| 1476P Immunohistochemical (mIHC) analyses of the immune tumor microenvironment (I-TME) in metastatic renal cell carcinoma (mRCC) patients (pts) receiving immunotherapy: Main results from the Meet-URO 18 study | 1-gen-2022 | Rebuzzi, S. E.; Rescigno, P.; Signori, A.; Brunelli, M.; Galuppini, F.; Vellone, V. G.; Gaggero, G.; Maruzzo, M.; Milella, M.; Vignani, F.; Cavo, A.; Basso, U.; Catalano, F.; Murianni, V.; Cremante, M.; Damassi, A.; Llaja Obispo, M. A.; Banna, G. L.; Buti, S.; Fornarini, G. | |
| 802TiP Immune tumor microenvironment (TME) in correlation with peripheral blood immune biomarkers as prognostic factor in metastatic renal cell carcinoma (mRCC) patients treated with nivolumab: The multicentric retrospective Meet-URO 18 study | 1-gen-2020 | Brunelli, M; Buti, S.; Rebuzzi, S. E.; Milella, M.; Vellone, V.; Bersanelli, M.; Maruzzo, M.; Basso, U.; Signori, A.; Martelli, V.; Catalano, F.; Damassi, A.; Murianni, V.; Merler, S.; Casartelli, C.; Fornarini, G. | |
| Beyond BRCA: The Emerging Significance of DNA Damage Response and Personalized Treatment in Pancreatic and Prostate Cancer Patients | 1-gen-2022 | Dalmasso, B.; Puccini, A.; Catalano, F.; Borea, R.; Iaia, M. L.; Bruno, W.; Fornarini, G.; Sciallero, S.; Rebuzzi, S. E.; Ghiorzo, P. | |
| Characterization of Tumor and Immune Tumor Microenvironment of Primary Tumors and Metastatic Sites in Advanced Renal Cell Carcinoma Patients Based on Response to Nivolumab Immunotherapy: Preliminary Results from the Meet-URO 18 Study | 1-gen-2023 | Rebuzzi, Sara Elena; Brunelli, Matteo; Galuppini, Francesca; Vellone, Valerio Gaetano; Signori, Alessio; Catalano, Fabio; Damassi, Alessandra; Gaggero, Gabriele; Rescigno, Pasquale; Maruzzo, Marco; Merler, Sara; Vignani, Francesca; Cavo, Alessia; Basso, Umberto; Milella, Michele; Panepinto, Olimpia; Mencoboni, Manlio; Sbaraglia, Marta; Dei Tos, Angelo Paolo; Murianni, Veronica; Cremante, Malvina; Llaja Obispo, Miguel Angel; Maffezzoli, Michele; Banna, Giuseppe Luigi; Buti, Sebastiano; Fornarini, Giuseppe | |
| Clinical Significance of Germline Pathogenic Variants among 51 Cancer Predisposition Genes in an Unselected Cohort of Italian Pancreatic Cancer Patients | 1-gen-2022 | Puccini, Alberto; Ponzano, Marta; Dalmasso, Bruna; Vanni, Irene; Gandini, Annalice; Puglisi, Silvia; Borea, Roberto; Cremante, Malvina; Bruno, William; Andreotti, Virginia; Allavena, Eleonora; Martelli, Valentino; Catalano, Fabio; Grassi, Massimiliano; Iaia, Maria Laura; Pirrone, Chiara; Pastorino, Alessandro; Fornarini, Giuseppe; Sciallero, Stefania; Ghiorzo, Paola; Pastorino, Lorenza | |
| Feasibility of multiple immunoexpression assay for immune tumor micrornvironment (I-TME) on matched metastatic and primary renal cell carcinoma (RCC) for patient prognostication and predictiveness to immunotherapy (preliminary analyses of the Meet URO 18 study). | 1-gen-2021 | Brunelli, Matteo; Rebuzzi, SARA ELENA; Vellone, VALERIO GAETANO; Sbaraglia, Marta; Gaggero, Gabriele; Fassan, Matteo; Maruzzo, Marco; Basso, Umberto; Bersanelli, Melissa; Damassi, Alessandra; Martelli, Valentino; Catalano, Fabio; Pierantoni, Francesco; Casartelli, Chiara; Merler, Sara; Businello, Gianluca; Milella, Michele; Buti, Sebastiano; Fornarini, Giuseppe | |
| The prognostic role of baseline metabolic tumor burden and systemic inflammation biomarkers in metastatic castration-resistant prostate cancer patients treated with Radium-223: A proof of concept study | 1-gen-2020 | Bauckneht, M.; Rebuzzi, S. E.; Signori, A.; Donegani, M. I.; Murianni, V.; Miceli, A.; Borea, R.; Raffa, S.; Damassi, A.; Ponzano, M.; Catalano, F.; Martelli, V.; Marini, C.; Boccardo, F.; Morbelli, S.; Sambuceti, G.; Fornarini, G. |